More on DFTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Definium Therapeutics (NQ:DFTX)
Delayed: 38.89 +1.16 (3.07%)
Prev. Close $37.73  
Open$37.73 
52 Wk High$ 
52 Wk Low$ 
Day High$39.37 
Day Low$37.73 
P/E N/A  
EPS$ 
Volume1,754,305 

Friends, Peers and Foes (?): CMPS, ATAI, GHRS, HELP, JNJ (more...)

Sep 11, 2026 11:36 AM Form 4 Definium Therapeutics, For: Sep 02 Filed by: Barrow Robert
Sep 10, 2026 07:00 AM Definium to present Phase 3 DT120 trial data at Psych Congress 2026
Sep 10, 2026 07:00 AM Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
Sep 2, 2026 08:50 AM Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Aug 31, 2026 03:13 PM Definium Therapeutics (DFTX) call put ratio 1 call to 1.9 puts as share price down 3.6%
Aug 31, 2026 09:25 AM Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Aug 31, 2026 05:16 AM Stifel on Definium Therapeutics (DFTX) Post Mgmt Dinner Meet: 'Confident Overall in Regulatory/Commercial Dynamics'
Aug 26, 2026 07:01 AM Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Aug 17, 2026 04:53 PM BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
Aug 17, 2026 04:01 PM Definium Therapeutics Announces New Employee Inducement Grants
View All Articles

Entities mentioned with DFTX

View All Entities